Company / Cash per Share
AVADEL PHARMACEUTICALS PLC Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.54
FY2024
5-year range
$0.39 / $1.31
FY2020-FY2024
Trend
+38.9%
vs FY2023
Sector context
#166 of 205
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's cash per share of $0.54 is lower than 81% of companies in the Health Care sector (FY2024). Cash per Share has fluctuated over the past 10 years, ranging from $0.25 in FY2018 to $1.49 in FY2015.
Based on SEC 10-K filings.
0.54 in FY2024 with a 5-year CAGR of +15.6%.
Declined from $1.23 to $0.54 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -14.6%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 205This company $0.54 Sector average $72.93
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 38.9% year-over-year.
- Ranks #166 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2015.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.54 | +38.9% |
| FY2023 | $0.39 | -68.4% |
| FY2022 | $1.23 | +42.1% |
| FY2021 | $0.87 | -33.6% |
| FY2020 | $1.31 | +399.6% |
| FY2019 | $0.26 | +4.6% |
| FY2018 | $0.25 | -37.0% |
| FY2017 | $0.40 | -58.3% |
| FY2016 | $0.95 | -36.3% |
| FY2015 | $1.49 | +35.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026